BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18661349)

  • 1. Versican in health and disease.
    Theocharis AD
    Connect Tissue Res; 2008; 49(3):230-4. PubMed ID: 18661349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological role and regulation of versican levels in cancer.
    Ricciardelli C; Sakko AJ; Ween MP; Russell DL; Horsfall DJ
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):233-45. PubMed ID: 19160015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versican: signaling to transcriptional control pathways.
    Rahmani M; Wong BW; Ang L; Cheung CC; Carthy JM; Walinski H; McManus BM
    Can J Physiol Pharmacol; 2006 Jan; 84(1):77-92. PubMed ID: 16845893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versican.
    Lebaron RG
    Perspect Dev Neurobiol; 1996; 3(4):261-71. PubMed ID: 9117259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting.
    Theocharis AD; Skandalis SS; Tzanakakis GN; Karamanos NK
    FEBS J; 2010 Oct; 277(19):3904-23. PubMed ID: 20840587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycans in atherosclerosis and restenosis: key roles for versican.
    Wight TN; Merrilees MJ
    Circ Res; 2004 May; 94(9):1158-67. PubMed ID: 15142969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligation of TLR2 by versican: a link between inflammation and metastasis.
    Wang W; Xu GL; Jia WD; Ma JL; Li JS; Ge YS; Ren WH; Yu JH; Liu WB
    Arch Med Res; 2009 May; 40(4):321-3. PubMed ID: 19608024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, function and regulation of versican: the most abundant type of proteoglycan in the extracellular matrix.
    Sotoodehnejadnematalahi F; Burke B
    Acta Med Iran; 2013; 51(11):740-50. PubMed ID: 24390942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of versican in cancer biology--tumorigenesis, progression and metastasis.
    Du WW; Yang W; Yee AJ
    Histol Histopathol; 2013 Jun; 28(6):701-13. PubMed ID: 23519970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer.
    Skandalis SS; Theocharis AD; Papageorgakopoulou N; Vynios DH; Theocharis DA
    Biochimie; 2006 Sep; 88(9):1135-43. PubMed ID: 16690200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix: a matter of life and death.
    Marastoni S; Ligresti G; Lorenzon E; Colombatti A; Mongiat M
    Connect Tissue Res; 2008; 49(3):203-6. PubMed ID: 18661343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-11 promotes the progress of gastric carcinoma via abnormally expressed versican.
    Zhang Z; Zhang J; Miao L; Liu K; Yang S; Pan C; Jiao B
    Int J Biol Sci; 2012; 8(3):383-93. PubMed ID: 22393310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-related decorin and versican expression in human laryngeal cancer.
    Stylianou M; Skandalis SS; Papadas TA; Mastronikolis NS; Theocharis DA; Papageorgakopoulou N; Vynios DH
    Anticancer Res; 2008; 28(1A):245-51. PubMed ID: 18383852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-dependent self-association of the C-type lectin domain of versican.
    Ney A; Booms P; Epple G; Mörgelin M; Guo G; Kettelgerdes G; Gessner R; Robinson PN
    Int J Biochem Cell Biol; 2006 Jan; 38(1):23-9. PubMed ID: 16159712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of versican with its binding partners.
    Wu YJ; La Pierre DP; Wu J; Yee AJ; Yang BB
    Cell Res; 2005 Jul; 15(7):483-94. PubMed ID: 16045811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development.
    Leeming DJ; Bay-Jensen AC; Vassiliadis E; Larsen MR; Henriksen K; Karsdal MA
    Biomarkers; 2011 May; 16(3):193-205. PubMed ID: 21506694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versican in inflammation and tissue remodeling: the impact on lung disorders.
    Andersson-Sjöland A; Hallgren O; Rolandsson S; Weitoft M; Tykesson E; Larsson-Callerfelt AK; Rydell-Törmänen K; Bjermer L; Malmström A; Karlsson JC; Westergren-Thorsson G
    Glycobiology; 2015 Mar; 25(3):243-51. PubMed ID: 25371494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versican expression during skeletal/joint morphogenesis and patterning of muscle and nerve in the embryonic mouse limb.
    Snow HE; Riccio LM; Mjaatvedt CH; Hoffman S; Capehart AA
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Feb; 282(2):95-105. PubMed ID: 15633171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progression.
    Theocharis AD; Tsolakis I; Tzanakakis GN; Karamanos NK
    Adv Pharmacol; 2006; 53():281-95. PubMed ID: 17239771
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracellular versican expression in mesenchymal spindle cell tumors contrasts with extracellular expression in epithelial and other tumors--a tissue microarray-based study.
    Bhardwaj A; Frankel WL; Pellegata NS; Wen P; Prasad ML
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):263-6. PubMed ID: 18301243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.